高风险局部前列腺癌的新辅助系统疗法:当前证据和未来方向
Abdullah Al-Khanaty1, David Hennes2, Marlon L Perera3
1Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Surgery, Austin Health, University of Melbourne, Melbourne, Australia.
European urology focus
|December 7, 2025
概括
针对高风险前列腺癌 (PC) 的全身新辅助疗法在手术前缩小瘤方面显示出有前途. 然而,目前的证据缺乏明确的生存益处,需要进一步的大规模试验进行临床推.
科学领域:
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 医学瘤学 医学瘤学
背景情况:
- 高风险前列腺癌 (PC) 具有显著的死亡风险.
- 根性前列腺切除术 (RP) 是标准的,但微转移性疾病会导致复发.
- 术后期是加强全身治疗的窗口.
研究的目的:
- 对高风险局部和局部晚期前列腺癌的全身新辅助疗法进行审查.
- 评估新辅助治疗对病理结果和存活率的影响.
- 评估PC中新辅助疗法的当前证据和未来方向.
主要方法:
- 早期新辅助药试验的综述 (雄激素剥夺疗法,多塞).
- 分析涉及受体通路抑制剂的试验.
- 考虑新兴疗法,如放射性体疗法和基因组方法.
主要成果:
- 新辅助性雄激素剥夺疗法改善了病理发现,但没有改善生存率.
- 多塞塔克塞尔化疗显示可行性和潜在的长期益处,但短期数据是不确定的.
- 雄激素受体通路抑制剂显示病态衰退和生物活性;正在进行第3阶段的PROTEUS试验.
结论:
- 目前没有3期数据支持PC的RP之前的常规新辅助系统治疗.
- 国际指导方针不建议这种策略.
- 目前正在进行的大规模试验对于确定新辅助疗法在临床实践中的作用至关重要.
关键词:
安卓素剥夺疗法是一种安卓素剥夺治疗.雄激素受体通路抑制剂化疗 化疗是一种化学疗法.新辅助疗法是一种新辅助疗法.在 PARP 抑制剂.在外科手术期间进行治疗.前列腺癌是什么意思 前列腺癌是什么意思前列腺特异性膜抗原无线电配体疗法进行激进的前列腺切除术.更多相关视频
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.7K
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.0K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Survival Analysis
630
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
630
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Cancer Vaccines
932
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
932
